Yonhap Infomax NewsSK Biopharmaceuticals has secured global rights to a second radiopharmaceutical candidate, WT-7695, from WARF, strengthening its oncology pipeline and expanding its RPT portfolio following last year's SKL35501 acquisition.
#YonhapInfomax #SKBiopharmaceuticals #Radiopharmaceutical #WT7695 #WARF #OncologyPipeline #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=92837
#YonhapInfomax #SKBiopharmaceuticals #Radiopharmaceutical #WT7695 #WARF #OncologyPipeline #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=92837
SK Biopharmaceuticals Strengthens Pipeline with Second Radiopharmaceutical Candidate Acquisition
SK Biopharmaceuticals has secured global rights to a second radiopharmaceutical candidate, WT-7695, from WARF, strengthening its oncology pipeline and expanding its RPT portfolio following last year's SKL35501 acquisition.